Post-kala-azar dermal leishmanaisis (PKDL) in Sudan is associated with elevated interferon-g (IFN-g). To study interferon-g pathways in PKDL, we genotyped 80 trios from the Masalit ethnic group for polymorphisms at À470 ins/delTT, À270T/C, À56T/ C and þ 95T/C in IFNGR1 and at À179G/A and þ 874T/A in IFNG. No associations occurred at IFNG. Global association with haplotypes comprising all four markers at IFNGR1 (w 2 10df ¼ 21.97, P ¼ 0.015) was observed, associated with a significant (w 2 1df ¼ 4.54, P ¼ 0.033) bias in transmission of the haplotype insTT T T T and less (w 2 1df ¼ 5.59, P ¼ 0.018) than expected transmission of insTT C C C. When compared with data on malaria associations from Gambia, the results suggest a complex pattern of haplotypic variation at the IFNGR1 promoter locus associated with different infectious disease in African populations that reflect the complex roles of IFN-g in parasite killing versus inflammation and pathogenesis. Genes and Immunity (2007) In Sudan, more than 50% of cases successfully treated for visceral symptoms caused by Leishmania donovani go on to develop post-kala-azar dermal leishmaniasis (PKDL). IFNG and IFNGR1, located on chromosomes 12q15 and 6q23, 3 are important candidate genes for PKDL. Rare mutations in the coding region of IFNGR1 are the cause of Mendelian inheritance of susceptibility to nontuberculous mycobacteria in consanguineous families. [5] [6] [7] Compound heterozygosity for rare alleles at IFNGR1 was also associated with disseminated infection with nontuberculous mycobacteria, and impaired cellular response to IFN-g, in a child born to non-consanguinous parents. 8 In mapping this deficiency, a CA repeat in intron 5 of IFNGR1 was identified and designated FA1. 8 We found that FA1 was linked and associated specifically with PKDL and not visceral leishmaniasis (VL) per se, in the Masalit ethnic group in Sudan. To understand natural population variation at IFNGR1, sequence analysis of the promoter locus between À1400 and þ 100 of the translational start site was undertaken in 140 Gambian chromosomes.
In Sudan, more than 50% of cases successfully treated for visceral symptoms caused by Leishmania donovani go on to develop post-kala-azar dermal leishmaniasis (PKDL). 1 Interferon-g (IFN-g) is a key T helper 1 and natural killer cell cytokine. It activates macrophages to kill parasites, 2 exerting its effects through its receptor IFNGR1. IFN-g is present in PKDL lesions and PKDL is associated with elevated antigen-specific IFN-g T-cell responses. 3, 4 IFNG and IFNGR1, located on chromosomes 12q15 and 6q23, 3 are important candidate genes for PKDL. Rare mutations in the coding region of IFNGR1 are the cause of Mendelian inheritance of susceptibility to nontuberculous mycobacteria in consanguineous families. [5] [6] [7] Compound heterozygosity for rare alleles at IFNGR1 was also associated with disseminated infection with nontuberculous mycobacteria, and impaired cellular response to IFN-g, in a child born to non-consanguinous parents. 8 In mapping this deficiency, a CA repeat in intron 5 of IFNGR1 was identified and designated FA1. 8 We found that FA1 was linked and associated specifically with PKDL and not visceral leishmaniasis (VL) per se, in the Masalit ethnic group in Sudan. 9 To understand natural population variation at IFNGR1, sequence analysis of the promoter locus between À1400 and þ 100 of the translational start site was undertaken in 140 Gambian chromosomes. 10 This identified 3 T-to-C single nucleotide polymorphisms (SNPs) at þ 95, À56 and À270 nucleotides and a TT deletion at À470/À471 nucleotides. Variant alleles at the À56 bp (T/C alleles at frequency 0.5) and þ 95 bp SNPs (C allele 0.49) were common and heterozygotes for the À56 bp SNP were protected against cerebral malaria and death from cerebral malaria. 10 Variant alleles at À270 (C allele 0.02) and À470 (delTT allele 0.11) were less frequent in Gambia. Nevertheless, for the Mandinka ethnic group, the double deletion at À470 bp was protective against severe malaria. No associations were observed for any of these polymorphisms with pulmonary tuberculosis caused by Mycobacterium tuberculosis in Gambians 11 or at À56T/C in Croatians. 12 Two possible functional polymorphisms occur at IFNG. The þ 874A/T SNP in intron 1 lies within a nuclear factor kB binding site and the variant T allele is in complete linkage disequilibrium (LD) with a CA repeat allele associated with high IFN-g production. 13 A À179 G/A SNP in the proximal promoter also controls gene transcription. 14 The aim of the present study was to determine whether further information on the association between PKDL and the IFN-g pathway could be obtained by genotyping additional SNPs at IFNGR1, as well as the putative function-associated SNPs at IFNG. Samples were collected from two adjacent villages, Um Salala and El-Rugab, in the highly endemic area of eastern Sudan. All individuals were from the Masalit tribe, which is highly susceptible to VL and PKDL. Details of the site and diagnostic criteria for PKDL were described previously. 9 Ethical approval for this study was from the Local Research Ethics Committee of the University of Khartoum. DNA from buccal swabs from 80 trios was genotyped for the À470 ins/del, À270T/C, À56T/C (rs2234711) and þ 95 (rs7749390) SNPs at IFNGR1 and the À179G/A (rs2069709) and þ 874 (rs2430561) SNPs at IFNG. Tests using genetically independent family members confirmed that all four IFNGR1 polymorphisms and the two IFNG gene SNPs were in Hardy-Weinberg equilibrium (HWE) (P40.05). As determined for Gambian populations (0.49 and 0.56, respectively).
10 the frequencies of the minor allele in IFNGR1 þ 95C and IFNGR1 À56C were high (0.45 and 0.46, respectively). Frequencies for minor alleles À270C and À470delTT were 0.05 and 0.03 in the Masalit, compared to 0.02 and 0.11 in Mandinka Gambians. Eleven haplotypes were present in the Masalit (Table 1) , five of which were not reported at frequencies 41% for the Mandinka. 10 Of interest is the presence in the Masalit of two haplotypes, insTT T C T at 16% and insTT T T C at 16%, that were present at 3 and 2% in the Mandinka. 10 Minor allele frequencies at IFNG À179G/A and þ 874A/T were 0.06 and 0.1 in the Masalit. Our sample of 80 trios had B90% power to detect an odds ratio of 3 at Po0.05 for minor allele/haplotype frequency of 0.4, but o50% where the frequency is o0.05.
Single marker transmission disequilibrium tests carried out using TRANSMIT (Table 2) showed a significant bias in transmission of alleles at IFNGR1 À270T/C (w 2 1df ¼ 6.98, P ¼ 0.0087) from heterozygous parents to PKDL offspring, but not for other IFNGR1 or IFNG (data not shown) markers. Conditional logistic regression showed that PKDL was associated with the common T allele at IFNGR1 À270 (odds ratio 3.67; 95% CI 1.02-13.45; P ¼ 0.045), whereas the minor C allele was associated with protection (odds ratio 0.27; 95% CI 0.08-0.98; P ¼ 0.046). Considering the complex haplotypic structure observed for the four promoter locus polymorphisms in African populations, we also looked for haplotype associations using TRANSMIT ( Table 2) . Haplotype analysis using all four markers showed a significant (P ¼ 0.015) global w 2 (21.97) on 10 df, associated with a significant (w 2 1df ¼ 4.54, P ¼ 0.033) bias in transmission of haplotype insTT T T T but not in transmission of the haplotypes insTT T C C or insTT T C T. This suggests involvement of a functional variant in PKDL susceptibility that is in LD with the À56 bp SNP (underlined), even though single marker analysis did not show a significant association with PKDL disease. The global haplotype association for all four markers was also associated with significantly (w 2 1df ¼ 5.59, P ¼ 0.033) less than expected transmission of haplotype insTT C C T that is at low frequency (2%) in the Masalit. Significant associations (Table 2) for three marker (e.g. insTT C C; insTT C T) and two marker (e.g. C C and C T for À270/ À56) haplotypes were also associated with less than expected transmission of haplotypes carrying the À270C allele (underlined), that is, independent of variation at the À56 bp SNP. The involvement of more than one etiological variant across the IFNGR1 promoter locus in determining susceptibility to, or protection against, . IFN-g provides first line defense against infectious diseases by activating macrophages to kill intracellular pathogens. IFN-g is also part of an inflammatory response that, if exaggerated, can be associated with adverse pathology. In VL, IFN-g production is low at diagnosis and increases with treatment and clinical cure from visceral symptoms in all patients. 4 However, peripheral blood mononuclear cells from patients who go on to develop PKDL show elevated proliferative and IFN-g responses to Leishmania antigen compared to patients who do not, with no differences in interleukin (IL)-4, IL-5 or IL-10. 4 Our study shows that this elevated IFN-g response in PKDL patients does not appear to be associated with polymorphisms at the IFNG gene, despite studies showing high IFN-g associated with the þ 874 bp T allele and low IFN-g with the A/A genotype. 13 Failure to detect associations with PKDL could be due to low frequency for variant alleles at IFNG SNPs in the Masalit.
PKDL lesions contain parasites and antigen, and an inflammatory infiltrate comprising macrophages, lym- DNA from buccal swabs from 80 trios was amplified using Multiple Displacement Amplification (Molecular Staging, USA; now supplied by Qiagen). The À470 ins/del, À270 and +95 (rs7749390) SNPs at IFNGR1 and the +874 SNP (rs2430561) at IFNG were genotyped by Amplification Refractory Mutational System PCR using primers as described. 10, 13 Restriction fragment length polymorphisms were used to genotype the IFNGR1 À56T/C SNP (rs2234711) and the IFNG À179G/A SNP (rs2069709). PCR primers were as follows: 0 . PCR products digested with Ava11 (IFNG À179) and Bts1 (IFNGR1 À56) were visualized on 1.5% agarose gels. Tests for deviation from Hardy-Weinberg equilibrium (HWE) for genotype data, and LD (D 0 values range from 0 for no LD to 1 for full LD) between markers, were performed within STATA v8.0 (Electronic database information 1) using the GenAssoc package available from Electronic database information 2. Haplotype probabilities were estimated on the basis of maximum likelihood calculations performed within the TRANSMIT program (Electronic database information 3), using data from the Masalit families with PKDL from Sudan, and as previously reported, 10 from Mandinka families with severe malaria from Gambia. Only haplotypes with an estimated probability of 41% were reported for the Mandinka. Markers are shown in chromosomal order (i.e. IFNGR1 À470, À270, À56 and +95).
phocytes and plasma cells.
3 IL-10 is the most prominent cytokine in lesions, but IFN-g is always present and IL-4 occurs in most lesions. 3 One reason for failure of IFN-g to activate macrophages to kill Leishmania in lesions could be inhibitory IL-10. Another, possibly related to the action of IL-10, could be failure to adequately express IFNGR1 owing to regulatory polymorphisms in the gene. Previously, 9 we demonstrated association between different alleles at the non-functional FA1 IFNGR1 microsatellite 8 and susceptibility to, or protection from, PKDL. Using a larger sample of PKDL trios, we genotyped the four promoter locus polymorphisms at IFNGR1, some or all of which may regulate IFNGR1 expression. These were originally identified in Gambians, 10 where the rare variant allele À470delTT was associated with all severe malaria in the Mandinka ethnic group, whereas heterozygosity at the À56T/C SNP was associated with protection from cerebral malaria. In our study, we found no direct association between PKDL and either À470 or À56 bp polymorphisms. However, markedly different frequencies of certain haplotypes across the four promoter locus polymorphisms were observed when comparing the Masalit from Sudan with the Mandinka from Gambia. In particular, we found that two haplotypes, insTT T T C and insTT T C T that were rare (2 and 3%, respectively) in the Mandinka, were more common (both 16%) in the Masalit. Whereas the common haplotype insTT T T T was significantly associated with PKDL, insTT T T C T and insTT T C C showed no bias in transmission to PKDL patients, suggesting that a functional variant in LD with the À56 bp SNP (at position 3 in these haplotypes) might contribute to susceptibility to PKDL even though we found no direct association with the À56 bp SNP itself. In addition, we found that the rare À270C allele and haplotypes that contained this variant were associated with protection from PKDL, independent of variation at the À56 bp SNP. This suggests that a complex pattern of haplotypic variants exists in different African ethnic groups that may relate to differing exposures and susceptibilities to infectious disease. In this respect, it is interesting that the Masalit have a larger range of haplotypes involving the À270C allele, which are protective for PKDL, compared to the Mandinka.
At present, there is little data to determine whether these promoter locus variants are functional in determining IFNGR1 expression. Although experimental studies 15 show differences in luciferase reporter gene activity associated with variants at À56 T/C, with lower activity for the C allele, our studies suggest that this SNP itself does not contribute to PKDL, but could be in LD with a functional SNP on different haplotypes. Malaria is endemic in the region of Sudan where the present work on PKDL took place, but transmission is highly seasonal and the incidence of severe malaria is low. In the Masalit, the À56 bp C and T alleles are both common, which could relate to heterozygous advantage against cerebral malaria shown for this SNP. 10 However, Jü liger et al. 15 also failed to find a direct association between this SNP and either mild or severe malaria in Gabonese children, suggesting that the earlier association with protection from cerebral malaria 10 might also be due to haplotypic variation between Gambians and Gabonese and a functional variant in LD with this SNP rather than À56 T/C itself. Further experimental analysis will be important in elucidating the role of regulatory polymorphisms at IFNGR1 in determining susceptibility to these important clinical manifestations of protozoan parasitic diseases throughout Africa.
